Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Clinical and constructed carbapenemase-producing Enterobacterales

PROVIDER: PRJNA892093 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21973100.fastq.gz	Fastqsanger.gz
	SRR21973101.fastq.gz	Fastqsanger.gz
	SRR21973102.fastq.gz	Fastqsanger.gz
	SRR21973103_1.fastq.gz	Fastqsanger.gz
	SRR21973103_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 71

Similar Datasets

Project description:Clinical carbapenemase/AmpC-producing Enterobacterales isolates

| PRJNA763348 | ENA

Clinical Evaluation of Advanced MALDI-TOF MS for Carbapenemase Subtyping in Gram-negative Isolates

Project description:The spread of carbapenemase-producing Enterobacterales (CPE) is emerging as a significant clinical concern in tertiary hospitals and in particular, long-term care facilities with deficiencies in infection control. This study aims to evaluate an advanced matrix-assisted laser desorption/ionization mass spectrometry (A-MALDI) method for the identification of carbapenemases and further discrimination of their subtypes in clinical isolates. The A-MALDI method was employed to detect CPE target proteins. Enhancements were made to improve detectability and mass accuracy through the optimization of MALDI-TOF settings and internal mass calibration. A total of 581 clinical isolates were analyzed, including 469 CPE isolates (388 KPC, 51 NDM, 40 OXA, and 2 GES) and 112 carbapenemase-negative isolates. Clinical evaluation of the A-MALDI demonstrated 100% accuracy and precision in identifying all the collected CPE isolates. Additionally, A-MALDI successfully discriminated individual carbapenemase subtypes (KPC-2 or KPC-3/4; OXA-48 or OXA-181 or OXA-232; GES-5 or GES-24) and also differentiated co-producing carbapenemase strains (KPC & NDM; KPC & OXA; KPC & GES; NDM & OXA), attributed to its high mass accuracy and simultaneous detection capability. A-MALDI is considered a valuable diagnostic tool for accurately identifying CPE and carbapenemase’s subtypes in clinical isolates. It may also aid in selecting appropriate antibiotics for each carbapenemase subtype. Ultimately, we expect that the A-MALDI method will contribute to preventing the spread of antibiotic resistance and improving human public health.

2024-11-26 | PXD058284 | Pride

Project description:Genomic Analysis of Clinical Carbapenemase Producing Enterobacterales

| PRJNA1103084 | ENA

Project description:Double-carbapenemase-producing Enterobacterales

| PRJNA1104021 | ENA

Enterobacterales

Project description:Genomic surveillance of carbapenemase-producing Enterobacterales

| PRJDB16280 | ENA

Project description:non-carbapenemase-producing carbapenem-resistant enterobacterales

| PRJNA1050050 | ENA

Project description:Complete genomic sequence of carbapenemase producing Enterobacterales

| PRJNA858561 | ENA

Project description:Carbapenemase producing Enterobacterales isolated in Western Normandy

| PRJNA1168500 | ENA

Project description:Hybrid assemblies of Carbapenemase-producing Enterobacterales (CPE)

| PRJNA1171009 | ENA

Project description:ESBL-producing Enterobacterales Clinical Isolates

| PRJNA1191487 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data